Top news

View all

More than US$ 1.8 billion in support for African vaccine manufacturing, catching up missed children and pandemic preparedness approved as Gavi Board steps up efforts to tackle backsliding and fight health emergencies

Gavi’s Board today approved the establishment of the African Vaccine Manufacturing Accelerator (AVMA), a financing instrument that will make up to US$ 1 billion available to support sustainable vaccine manufacturing in Africa.

Gavi expands portfolio, introduces new vaccine programmes to save more lives and support child health

Countries can now submit plans to introduce diphtheria, tetanus and pertussis (DTP)-containing vaccine boosters (DTP boosters) and the six-in-one hexavalent vaccine.

Togo introduces human papillomavirus vaccine to protect adolescent girls from the leading cause of cervical cancer

The Government of Togo will introduce the human papillomavirus (HPV) vaccine its into routine immunisation system to prevent cervical cancer on Monday, 4 December 2023. Several other local partners, and the private health sector, are supporting…

COVAX data brief

Regular snapshot of latest information on key COVAX data points, including shipments, donations, coverage, administration, absorption and delivery support. Published once a month.

View all

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

VaccinesWork

 

Vaccines are one of the most successful and cost-effective health investments in history with wider benefits that accrue across a lifetime.

Keep informed about the latest topics in global health, including top stories related to the ongoing coronavirus (COVID-19) outbreak.

Learn more

Top VaccinesWork stories

View all stories

Christmas tree syndrome: why the festive evergreen can make your nose run – and what you can do about it

People who usually suffer from allergies are most at risk.

Nearly half of COVID-19 survivors in Africa experiencing Long COVID symptoms, study suggests

Fatigue is the most commonly reported symptom among COVID-19 survivors in Africa.

New research links nanoplastics to Parkinson’s and some types of dementia

A new study links nanoplastics to Parkinson's disease, suggesting they may trigger brain changes linked to the condition and some types of dementia. 

COVID-19 vaccines

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Accurate, evidence-based information about COVID-19 vaccines to provide people with essential facts about the vaccines that will help end this crisis.

Learn more

Our impact

Children >1 billion children vaccinated through routine programmes
First aid locator >17.3 million future deaths averted
Transitioned 19 countries fully self-financing
Billions >220.5 US$ billion in economic benefits for countries
Syringe 1.8 billion vaccinations through preventive vaccination campaigns

Our mission: save lives and protect people's health

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Saving lives and protecting people’s health by increasing equitable and sustainable use of vaccines.

Learn more

Our partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.

Meet the Vaccine Alliance partners

Subscribe to our newsletter